nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CYP3A4—type 2 diabetes mellitus	0.137	0.534	CbGaD
Telaprevir—ALB—type 2 diabetes mellitus	0.12	0.466	CbGaD
Telaprevir—ORM1—Nateglinide—type 2 diabetes mellitus	0.0592	0.132	CbGbCtD
Telaprevir—ALB—Gliclazide—type 2 diabetes mellitus	0.0386	0.086	CbGbCtD
Telaprevir—ALB—Repaglinide—type 2 diabetes mellitus	0.0363	0.0808	CbGbCtD
Telaprevir—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0303	0.0674	CbGbCtD
Telaprevir—ALB—Valsartan—type 2 diabetes mellitus	0.0268	0.0596	CbGbCtD
Telaprevir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0267	0.0593	CbGbCtD
Telaprevir—ALB—Nateglinide—type 2 diabetes mellitus	0.0249	0.0554	CbGbCtD
Telaprevir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0238	0.0529	CbGbCtD
Telaprevir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0172	0.0382	CbGbCtD
Telaprevir—ALB—Glyburide—type 2 diabetes mellitus	0.0168	0.0374	CbGbCtD
Telaprevir—CMA1—tunica intima—type 2 diabetes mellitus	0.0166	0.265	CbGeAlD
Telaprevir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.016	0.0355	CbGbCtD
Telaprevir—ALB—Losartan—type 2 diabetes mellitus	0.0154	0.0342	CbGbCtD
Telaprevir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0142	0.0317	CbGbCtD
Telaprevir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.013	0.029	CbGbCtD
Telaprevir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0263	CbGbCtD
Telaprevir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0114	0.0253	CbGbCtD
Telaprevir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0229	CbGbCtD
Telaprevir—ABCB1—Glyburide—type 2 diabetes mellitus	0.0088	0.0196	CbGbCtD
Telaprevir—ABCB1—Losartan—type 2 diabetes mellitus	0.00804	0.0179	CbGbCtD
Telaprevir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0078	0.0174	CbGbCtD
Telaprevir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00748	0.0166	CbGbCtD
Telaprevir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00748	0.0166	CbGbCtD
Telaprevir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00707	0.0157	CbGbCtD
Telaprevir—CTSK—leg—type 2 diabetes mellitus	0.0067	0.107	CbGeAlD
Telaprevir—CTSK—hindlimb—type 2 diabetes mellitus	0.00598	0.0954	CbGeAlD
Telaprevir—CMA1—artery—type 2 diabetes mellitus	0.00569	0.0907	CbGeAlD
Telaprevir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00527	0.0117	CbGbCtD
Telaprevir—CYP3A4—Losartan—type 2 diabetes mellitus	0.00482	0.0107	CbGbCtD
Telaprevir—CELA1—pancreas—type 2 diabetes mellitus	0.00369	0.0589	CbGeAlD
Telaprevir—CMA1—cardiovascular system—type 2 diabetes mellitus	0.00198	0.0315	CbGeAlD
Telaprevir—CMA1—adipose tissue—type 2 diabetes mellitus	0.00174	0.0278	CbGeAlD
Telaprevir—CTSS—islet of Langerhans—type 2 diabetes mellitus	0.00154	0.0246	CbGeAlD
Telaprevir—CTSK—retina—type 2 diabetes mellitus	0.00151	0.024	CbGeAlD
Telaprevir—CTSS—retina—type 2 diabetes mellitus	0.00132	0.021	CbGeAlD
Telaprevir—CTSK—cardiovascular system—type 2 diabetes mellitus	0.00127	0.0203	CbGeAlD
Telaprevir—CTSK—kidney—type 2 diabetes mellitus	0.00125	0.0199	CbGeAlD
Telaprevir—CTSK—pancreas—type 2 diabetes mellitus	0.00124	0.0197	CbGeAlD
Telaprevir—CMA1—liver—type 2 diabetes mellitus	0.00122	0.0195	CbGeAlD
Telaprevir—CTSK—adipose tissue—type 2 diabetes mellitus	0.00112	0.0179	CbGeAlD
Telaprevir—CTSS—cardiovascular system—type 2 diabetes mellitus	0.00112	0.0178	CbGeAlD
Telaprevir—CTSS—kidney—type 2 diabetes mellitus	0.00109	0.0174	CbGeAlD
Telaprevir—CTSS—pancreas—type 2 diabetes mellitus	0.00109	0.0173	CbGeAlD
Telaprevir—CTSS—cortex of kidney—type 2 diabetes mellitus	0.00106	0.017	CbGeAlD
Telaprevir—Boceprevir—CYP3A4—type 2 diabetes mellitus	0.00106	1	CrCbGaD
Telaprevir—CTSS—adipose tissue—type 2 diabetes mellitus	0.000985	0.0157	CbGeAlD
Telaprevir—CTSK—liver—type 2 diabetes mellitus	0.000788	0.0126	CbGeAlD
Telaprevir—CTSS—liver—type 2 diabetes mellitus	0.000691	0.011	CbGeAlD
Telaprevir—ORM1—liver—type 2 diabetes mellitus	0.000412	0.00657	CbGeAlD
Telaprevir—ALB—liver—type 2 diabetes mellitus	0.000362	0.00576	CbGeAlD
Telaprevir—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000273	0.00434	CbGeAlD
Telaprevir—CYP3A4—kidney—type 2 diabetes mellitus	0.000272	0.00434	CbGeAlD
Telaprevir—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000245	0.00172	CcSEcCtD
Telaprevir—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000244	0.00172	CcSEcCtD
Telaprevir—Infestation—Metformin—type 2 diabetes mellitus	0.000244	0.00172	CcSEcCtD
Telaprevir—Infestation NOS—Metformin—type 2 diabetes mellitus	0.000244	0.00172	CcSEcCtD
Telaprevir—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000243	0.00171	CcSEcCtD
Telaprevir—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000241	0.0017	CcSEcCtD
Telaprevir—Nausea—Tolazamide—type 2 diabetes mellitus	0.000241	0.0017	CcSEcCtD
Telaprevir—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000241	0.0017	CcSEcCtD
Telaprevir—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000239	0.00168	CcSEcCtD
Telaprevir—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000238	0.00167	CcSEcCtD
Telaprevir—Rash—Nateglinide—type 2 diabetes mellitus	0.000237	0.00167	CcSEcCtD
Telaprevir—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000237	0.00167	CcSEcCtD
Telaprevir—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000236	0.00166	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000235	0.00165	CcSEcCtD
Telaprevir—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000235	0.00165	CcSEcCtD
Telaprevir—Anaemia—Glyburide—type 2 diabetes mellitus	0.000235	0.00165	CcSEcCtD
Telaprevir—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000234	0.00165	CcSEcCtD
Telaprevir—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000233	0.00164	CcSEcCtD
Telaprevir—ABCB1—retina—type 2 diabetes mellitus	0.000233	0.00371	CbGeAlD
Telaprevir—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000233	0.00164	CcSEcCtD
Telaprevir—Nausea—Acarbose—type 2 diabetes mellitus	0.000232	0.00163	CcSEcCtD
Telaprevir—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000231	0.00163	CcSEcCtD
Telaprevir—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00023	0.00162	CcSEcCtD
Telaprevir—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000228	0.00161	CcSEcCtD
Telaprevir—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000226	0.00159	CcSEcCtD
Telaprevir—Infection—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00159	CcSEcCtD
Telaprevir—Nausea—Nateglinide—type 2 diabetes mellitus	0.000223	0.00157	CcSEcCtD
Telaprevir—Shock—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00157	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00157	CcSEcCtD
Telaprevir—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000223	0.00157	CcSEcCtD
Telaprevir—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00157	CcSEcCtD
Telaprevir—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00157	CcSEcCtD
Telaprevir—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00155	CcSEcCtD
Telaprevir—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00022	0.00155	CcSEcCtD
Telaprevir—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000219	0.0035	CbGeAlD
Telaprevir—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000218	0.00153	CcSEcCtD
Telaprevir—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000218	0.00153	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000217	0.00153	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000217	0.00153	CcSEcCtD
Telaprevir—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000217	0.00153	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00152	CcSEcCtD
Telaprevir—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00152	CcSEcCtD
Telaprevir—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000216	0.00152	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000215	0.00151	CcSEcCtD
Telaprevir—Urticaria—Glipizide—type 2 diabetes mellitus	0.000214	0.00151	CcSEcCtD
Telaprevir—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000211	0.00148	CcSEcCtD
Telaprevir—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000211	0.00148	CcSEcCtD
Telaprevir—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00021	0.00148	CcSEcCtD
Telaprevir—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000207	0.00146	CcSEcCtD
Telaprevir—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000207	0.00146	CcSEcCtD
Telaprevir—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000207	0.00145	CcSEcCtD
Telaprevir—Rash—Repaglinide—type 2 diabetes mellitus	0.000205	0.00145	CcSEcCtD
Telaprevir—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000205	0.00144	CcSEcCtD
Telaprevir—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000205	0.00144	CcSEcCtD
Telaprevir—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000205	0.00144	CcSEcCtD
Telaprevir—Eye disorder—Metformin—type 2 diabetes mellitus	0.000205	0.00144	CcSEcCtD
Telaprevir—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000204	0.00144	CcSEcCtD
Telaprevir—Shock—Glyburide—type 2 diabetes mellitus	0.000204	0.00144	CcSEcCtD
Telaprevir—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000204	0.00143	CcSEcCtD
Telaprevir—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000204	0.00143	CcSEcCtD
Telaprevir—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000203	0.00143	CcSEcCtD
Telaprevir—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000203	0.00143	CcSEcCtD
Telaprevir—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000203	0.00143	CcSEcCtD
Telaprevir—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000203	0.00143	CcSEcCtD
Telaprevir—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000201	0.00141	CcSEcCtD
Telaprevir—Urticaria—Glimepiride—type 2 diabetes mellitus	0.0002	0.00141	CcSEcCtD
Telaprevir—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000199	0.0014	CcSEcCtD
Telaprevir—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000197	0.00314	CbGeAlD
Telaprevir—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00138	CcSEcCtD
Telaprevir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00138	CcSEcCtD
Telaprevir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000194	0.00137	CcSEcCtD
Telaprevir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000194	0.00136	CcSEcCtD
Telaprevir—Nausea—Repaglinide—type 2 diabetes mellitus	0.000193	0.00136	CcSEcCtD
Telaprevir—Asthenia—Glipizide—type 2 diabetes mellitus	0.000193	0.00136	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000193	0.00136	CcSEcCtD
Telaprevir—ABCB1—kidney—type 2 diabetes mellitus	0.000193	0.00307	CbGeAlD
Telaprevir—ABCB1—pancreas—type 2 diabetes mellitus	0.000192	0.00305	CbGeAlD
Telaprevir—Malnutrition—Metformin—type 2 diabetes mellitus	0.000191	0.00134	CcSEcCtD
Telaprevir—Pruritus—Glipizide—type 2 diabetes mellitus	0.000191	0.00134	CcSEcCtD
Telaprevir—Syncope—Valsartan—type 2 diabetes mellitus	0.000188	0.00132	CcSEcCtD
Telaprevir—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000188	0.00299	CbGeAlD
Telaprevir—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000187	0.00132	CcSEcCtD
Telaprevir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000185	0.0013	CcSEcCtD
Telaprevir—Infection—Gliclazide—type 2 diabetes mellitus	0.000185	0.0013	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000184	0.0013	CcSEcCtD
Telaprevir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000184	0.0013	CcSEcCtD
Telaprevir—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000184	0.0013	CcSEcCtD
Telaprevir—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000184	0.0013	CcSEcCtD
Telaprevir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000183	0.00129	CcSEcCtD
Telaprevir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000183	0.00129	CcSEcCtD
Telaprevir—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000182	0.00128	CcSEcCtD
Telaprevir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000181	0.00127	CcSEcCtD
Telaprevir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00018	0.00127	CcSEcCtD
Telaprevir—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00127	CcSEcCtD
Telaprevir—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00018	0.00127	CcSEcCtD
Telaprevir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00127	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000179	0.00126	CcSEcCtD
Telaprevir—Dizziness—Glipizide—type 2 diabetes mellitus	0.000178	0.00125	CcSEcCtD
Telaprevir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000178	0.00125	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000177	0.00125	CcSEcCtD
Telaprevir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000177	0.00124	CcSEcCtD
Telaprevir—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000176	0.00124	CcSEcCtD
Telaprevir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000176	0.00124	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000175	0.00123	CcSEcCtD
Telaprevir—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000174	0.00277	CbGeAlD
Telaprevir—CYP3A4—liver—type 2 diabetes mellitus	0.000172	0.00274	CbGeAlD
Telaprevir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000172	0.00121	CcSEcCtD
Telaprevir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000171	0.00121	CcSEcCtD
Telaprevir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000171	0.00121	CcSEcCtD
Telaprevir—Syncope—Metformin—type 2 diabetes mellitus	0.000171	0.00121	CcSEcCtD
Telaprevir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000171	0.0012	CcSEcCtD
Telaprevir—Infection—Valsartan—type 2 diabetes mellitus	0.00017	0.0012	CcSEcCtD
Telaprevir—Rash—Glipizide—type 2 diabetes mellitus	0.00017	0.0012	CcSEcCtD
Telaprevir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00017	0.00119	CcSEcCtD
Telaprevir—Shock—Valsartan—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Telaprevir—Infection—Orlistat—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Telaprevir—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Telaprevir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Telaprevir—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000168	0.00118	CcSEcCtD
Telaprevir—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Telaprevir—Urticaria—Glyburide—type 2 diabetes mellitus	0.000165	0.00116	CcSEcCtD
Telaprevir—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000165	0.00116	CcSEcCtD
Telaprevir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000164	0.00116	CcSEcCtD
Telaprevir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00115	CcSEcCtD
Telaprevir—Syncope—Irbesartan—type 2 diabetes mellitus	0.000162	0.00114	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000161	0.00114	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000161	0.00113	CcSEcCtD
Telaprevir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000161	0.00113	CcSEcCtD
Telaprevir—Nausea—Glipizide—type 2 diabetes mellitus	0.00016	0.00113	CcSEcCtD
Telaprevir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00016	0.00113	CcSEcCtD
Telaprevir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000159	0.00112	CcSEcCtD
Telaprevir—Rash—Glimepiride—type 2 diabetes mellitus	0.000159	0.00112	CcSEcCtD
Telaprevir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000158	0.00111	CcSEcCtD
Telaprevir—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000158	0.00111	CcSEcCtD
Telaprevir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00111	CcSEcCtD
Telaprevir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00111	CcSEcCtD
Telaprevir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000158	0.00111	CcSEcCtD
Telaprevir—Anaemia—Losartan—type 2 diabetes mellitus	0.000157	0.0011	CcSEcCtD
Telaprevir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00109	CcSEcCtD
Telaprevir—Infection—Metformin—type 2 diabetes mellitus	0.000155	0.00109	CcSEcCtD
Telaprevir—Shock—Metformin—type 2 diabetes mellitus	0.000153	0.00108	CcSEcCtD
Telaprevir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000153	0.00108	CcSEcCtD
Telaprevir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000153	0.00107	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000152	0.00107	CcSEcCtD
Telaprevir—Syncope—Losartan—type 2 diabetes mellitus	0.000152	0.00107	CcSEcCtD
Telaprevir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000151	0.00107	CcSEcCtD
Telaprevir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00106	CcSEcCtD
Telaprevir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000149	0.00105	CcSEcCtD
Telaprevir—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000149	0.00105	CcSEcCtD
Telaprevir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00105	CcSEcCtD
Telaprevir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000149	0.00105	CcSEcCtD
Telaprevir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000148	0.00104	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000148	0.00104	CcSEcCtD
Telaprevir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000147	0.00104	CcSEcCtD
Telaprevir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000147	0.00103	CcSEcCtD
Telaprevir—Infection—Irbesartan—type 2 diabetes mellitus	0.000146	0.00103	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000146	0.00103	CcSEcCtD
Telaprevir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000146	0.00103	CcSEcCtD
Telaprevir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000145	0.00102	CcSEcCtD
Telaprevir—Shock—Irbesartan—type 2 diabetes mellitus	0.000145	0.00102	CcSEcCtD
Telaprevir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00102	CcSEcCtD
Telaprevir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000144	0.00101	CcSEcCtD
Telaprevir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000144	0.00101	CcSEcCtD
Telaprevir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Telaprevir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Telaprevir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Telaprevir—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000142	0.001	CcSEcCtD
Telaprevir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000142	0.000999	CcSEcCtD
Telaprevir—Infection—Losartan—type 2 diabetes mellitus	0.000137	0.000968	CcSEcCtD
Telaprevir—Shock—Losartan—type 2 diabetes mellitus	0.000136	0.000958	CcSEcCtD
Telaprevir—Urticaria—Valsartan—type 2 diabetes mellitus	0.000136	0.000957	CcSEcCtD
Telaprevir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000136	0.000955	CcSEcCtD
Telaprevir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000135	0.000954	CcSEcCtD
Telaprevir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000948	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000134	0.000947	CcSEcCtD
Telaprevir—Fatigue—Metformin—type 2 diabetes mellitus	0.000134	0.000945	CcSEcCtD
Telaprevir—Urticaria—Orlistat—type 2 diabetes mellitus	0.000134	0.000945	CcSEcCtD
Telaprevir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000134	0.00094	CcSEcCtD
Telaprevir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000132	0.000928	CcSEcCtD
Telaprevir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000132	0.000927	CcSEcCtD
Telaprevir—Rash—Glyburide—type 2 diabetes mellitus	0.000131	0.00092	CcSEcCtD
Telaprevir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000131	0.00092	CcSEcCtD
Telaprevir—Syncope—Ramipril—type 2 diabetes mellitus	0.00013	0.000918	CcSEcCtD
Telaprevir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000128	0.000899	CcSEcCtD
Telaprevir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000127	0.000897	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000127	0.000893	CcSEcCtD
Telaprevir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000127	0.000892	CcSEcCtD
Telaprevir—Urticaria—Metformin—type 2 diabetes mellitus	0.000124	0.000871	CcSEcCtD
Telaprevir—Nausea—Glyburide—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Telaprevir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000123	0.000865	CcSEcCtD
Telaprevir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000123	0.000864	CcSEcCtD
Telaprevir—ABCB1—liver—type 2 diabetes mellitus	0.000122	0.00194	CbGeAlD
Telaprevir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000121	0.000854	CcSEcCtD
Telaprevir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000121	0.000852	CcSEcCtD
Telaprevir—Pruritus—Orlistat—type 2 diabetes mellitus	0.00012	0.000842	CcSEcCtD
Telaprevir—Fatigue—Losartan—type 2 diabetes mellitus	0.000119	0.00084	CcSEcCtD
Telaprevir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000118	0.000833	CcSEcCtD
Telaprevir—Rash—Gliclazide—type 2 diabetes mellitus	0.000117	0.000826	CcSEcCtD
Telaprevir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000117	0.000826	CcSEcCtD
Telaprevir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000117	0.000824	CcSEcCtD
Telaprevir—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000117	0.000822	CcSEcCtD
Telaprevir—Shock—Ramipril—type 2 diabetes mellitus	0.000117	0.000822	CcSEcCtD
Telaprevir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000116	0.000819	CcSEcCtD
Telaprevir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000116	0.000818	CcSEcCtD
Telaprevir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000116	0.000814	CcSEcCtD
Telaprevir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000811	CcSEcCtD
Telaprevir—Dizziness—Valsartan—type 2 diabetes mellitus	0.000113	0.000796	CcSEcCtD
Telaprevir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000112	0.000787	CcSEcCtD
Telaprevir—Asthenia—Metformin—type 2 diabetes mellitus	0.000112	0.000787	CcSEcCtD
Telaprevir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000111	0.000779	CcSEcCtD
Telaprevir—Pruritus—Metformin—type 2 diabetes mellitus	0.00011	0.000776	CcSEcCtD
Telaprevir—Urticaria—Losartan—type 2 diabetes mellitus	0.00011	0.000774	CcSEcCtD
Telaprevir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000109	0.000766	CcSEcCtD
Telaprevir—Rash—Valsartan—type 2 diabetes mellitus	0.000108	0.000759	CcSEcCtD
Telaprevir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000108	0.000759	CcSEcCtD
Telaprevir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000107	0.000757	CcSEcCtD
Telaprevir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000107	0.00075	CcSEcCtD
Telaprevir—Rash—Orlistat—type 2 diabetes mellitus	0.000107	0.00075	CcSEcCtD
Telaprevir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000106	0.00075	CcSEcCtD
Telaprevir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000743	CcSEcCtD
Telaprevir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000104	0.000732	CcSEcCtD
Telaprevir—Dizziness—Metformin—type 2 diabetes mellitus	0.000103	0.000725	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.000721	CcSEcCtD
Telaprevir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000102	0.00072	CcSEcCtD
Telaprevir—Nausea—Valsartan—type 2 diabetes mellitus	0.000102	0.000715	CcSEcCtD
Telaprevir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000101	0.000708	CcSEcCtD
Telaprevir—Nausea—Orlistat—type 2 diabetes mellitus	0.0001	0.000707	CcSEcCtD
Telaprevir—Asthenia—Losartan—type 2 diabetes mellitus	9.93e-05	0.000699	CcSEcCtD
Telaprevir—Vomiting—Metformin—type 2 diabetes mellitus	9.91e-05	0.000697	CcSEcCtD
Telaprevir—Rash—Metformin—type 2 diabetes mellitus	9.82e-05	0.000691	CcSEcCtD
Telaprevir—Dermatitis—Metformin—type 2 diabetes mellitus	9.81e-05	0.000691	CcSEcCtD
Telaprevir—Pruritus—Losartan—type 2 diabetes mellitus	9.79e-05	0.000689	CcSEcCtD
Telaprevir—Dizziness—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000684	CcSEcCtD
Telaprevir—Diarrhoea—Losartan—type 2 diabetes mellitus	9.47e-05	0.000666	CcSEcCtD
Telaprevir—Urticaria—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000663	CcSEcCtD
Telaprevir—Vomiting—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000658	CcSEcCtD
Telaprevir—Rash—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000653	CcSEcCtD
Telaprevir—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000652	CcSEcCtD
Telaprevir—Nausea—Metformin—type 2 diabetes mellitus	9.25e-05	0.000651	CcSEcCtD
Telaprevir—Dizziness—Losartan—type 2 diabetes mellitus	9.15e-05	0.000644	CcSEcCtD
Telaprevir—Vomiting—Losartan—type 2 diabetes mellitus	8.8e-05	0.000619	CcSEcCtD
Telaprevir—Nausea—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000615	CcSEcCtD
Telaprevir—Rash—Losartan—type 2 diabetes mellitus	8.72e-05	0.000614	CcSEcCtD
Telaprevir—Dermatitis—Losartan—type 2 diabetes mellitus	8.72e-05	0.000614	CcSEcCtD
Telaprevir—Asthenia—Ramipril—type 2 diabetes mellitus	8.51e-05	0.000599	CcSEcCtD
Telaprevir—Pruritus—Ramipril—type 2 diabetes mellitus	8.39e-05	0.000591	CcSEcCtD
Telaprevir—Nausea—Losartan—type 2 diabetes mellitus	8.22e-05	0.000579	CcSEcCtD
Telaprevir—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000571	CcSEcCtD
Telaprevir—Dizziness—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000552	CcSEcCtD
Telaprevir—Vomiting—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000531	CcSEcCtD
Telaprevir—Rash—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000527	CcSEcCtD
Telaprevir—Dermatitis—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000526	CcSEcCtD
Telaprevir—Nausea—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000496	CcSEcCtD
Telaprevir—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.01e-05	0.000115	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1e-05	0.000115	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1e-05	0.000115	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.92e-06	0.000114	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.92e-06	0.000114	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	9.8e-06	0.000112	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	9.8e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PCK1—type 2 diabetes mellitus	9.78e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.63e-06	0.00011	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.59e-06	0.00011	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	9.53e-06	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	9.44e-06	0.000108	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	9.44e-06	0.000108	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.39e-06	0.000107	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	9.38e-06	0.000107	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	9.28e-06	0.000106	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	9.27e-06	0.000106	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—type 2 diabetes mellitus	9.22e-06	0.000106	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.19e-06	0.000105	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.19e-06	0.000105	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	9.16e-06	0.000105	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HK1—type 2 diabetes mellitus	9.16e-06	0.000105	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.15e-06	0.000105	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.14e-06	0.000105	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	9.11e-06	0.000104	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	9.11e-06	0.000104	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	9.11e-06	0.000104	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.96e-06	0.000103	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	8.89e-06	0.000102	CbGpPWpGaD
Telaprevir—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	8.84e-06	0.000101	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LPA—type 2 diabetes mellitus	8.84e-06	0.000101	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	8.84e-06	0.000101	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCKR—type 2 diabetes mellitus	8.84e-06	0.000101	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.81e-06	0.000101	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.77e-06	0.0001	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	8.76e-06	0.0001	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.71e-06	9.97e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.71e-06	9.97e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.69e-06	9.95e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	8.57e-06	9.8e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	8.52e-06	9.75e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—type 2 diabetes mellitus	8.51e-06	9.74e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.5e-06	9.73e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	8.48e-06	9.7e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.4e-06	9.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	8.39e-06	9.6e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	8.36e-06	9.57e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.31e-06	9.51e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	8.26e-06	9.45e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.24e-06	9.42e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	8.22e-06	9.41e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.12e-06	9.3e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.09e-06	9.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.07e-06	9.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	8.02e-06	9.18e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.98e-06	9.13e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	7.88e-06	9.02e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.85e-06	8.99e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.83e-06	8.96e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.75e-06	8.87e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	7.75e-06	8.87e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.75e-06	8.87e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	7.75e-06	8.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.67e-06	8.78e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.67e-06	8.78e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.58e-06	8.68e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.49e-06	8.58e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	7.43e-06	8.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.41e-06	8.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.41e-06	8.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.41e-06	8.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.41e-06	8.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.41e-06	8.48e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	7.36e-06	8.42e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	7.32e-06	8.38e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	7.32e-06	8.38e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	7.21e-06	8.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTR—type 2 diabetes mellitus	7.21e-06	8.25e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.17e-06	8.21e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.08e-06	8.11e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	7.07e-06	8.09e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.03e-06	8.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LIPC—type 2 diabetes mellitus	7.03e-06	8.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HBA1—type 2 diabetes mellitus	7.03e-06	8.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCK—type 2 diabetes mellitus	7.03e-06	8.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.98e-06	7.99e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.95e-06	7.96e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.91e-06	7.9e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.86e-06	7.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.78e-06	7.76e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.78e-06	7.75e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.78e-06	7.75e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.65e-06	7.6e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.64e-06	7.6e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	6.64e-06	7.6e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.6e-06	7.56e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.45e-06	7.38e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.32e-06	7.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.32e-06	7.23e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.3e-06	7.21e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.19e-06	7.09e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CTGF—type 2 diabetes mellitus	6.18e-06	7.08e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.16e-06	7.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.16e-06	7.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.16e-06	7.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	6.13e-06	7.01e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.12e-06	7e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.04e-06	6.92e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.04e-06	6.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.04e-06	6.91e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.01e-06	6.88e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	6e-06	6.86e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.94e-06	6.8e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.92e-06	6.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.83e-06	6.67e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.81e-06	6.65e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.81e-06	6.65e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.76e-06	6.6e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.71e-06	6.54e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.7e-06	6.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.7e-06	6.52e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.61e-06	6.42e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.61e-06	6.42e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.61e-06	6.42e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.56e-06	6.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.53e-06	6.33e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.52e-06	6.32e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.52e-06	6.32e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.52e-06	6.32e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.46e-06	6.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.46e-06	6.25e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.42e-06	6.2e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.37e-06	6.15e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.28e-06	6.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.26e-06	6.03e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.26e-06	6.01e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.05e-06	5.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.99e-06	5.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.99e-06	5.71e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.94e-06	5.66e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.91e-06	5.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.87e-06	5.57e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.79e-06	5.48e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.79e-06	5.48e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.78e-06	5.47e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.77e-06	5.46e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.77e-06	5.46e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.77e-06	5.46e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.77e-06	5.46e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.71e-06	5.39e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.71e-06	5.39e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.69e-06	5.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.62e-06	5.29e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.58e-06	5.24e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.49e-06	5.14e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.39e-06	5.02e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.37e-06	5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.29e-06	4.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.25e-06	4.87e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.2e-06	4.8e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	4.79e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.13e-06	4.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.13e-06	4.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.11e-06	4.7e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	4.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.05e-06	4.64e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	4.6e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.97e-06	4.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.93e-06	4.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.89e-06	4.45e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.89e-06	4.45e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-06	4.42e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.83e-06	4.38e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.82e-06	4.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.79e-06	4.34e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.79e-06	4.34e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.79e-06	4.34e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.79e-06	4.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.77e-06	4.31e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.76e-06	4.3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.7e-06	4.24e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.68e-06	4.21e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.67e-06	4.2e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.66e-06	4.19e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.66e-06	4.19e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.61e-06	4.13e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	4.11e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.57e-06	4.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	4.07e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.52e-06	4.03e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.4e-06	3.89e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.4e-06	3.89e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.4e-06	3.89e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.38e-06	3.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.34e-06	3.82e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.32e-06	3.8e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.31e-06	3.79e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.24e-06	3.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.21e-06	3.68e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.16e-06	3.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.15e-06	3.6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	3.58e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.11e-06	3.56e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.11e-06	3.56e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.08e-06	3.52e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.08e-06	3.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	3.51e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.05e-06	3.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.95e-06	3.38e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.95e-06	3.38e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.74e-06	3.14e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	3.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	3.08e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.69e-06	3.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.54e-06	2.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.54e-06	2.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.53e-06	2.9e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.5e-06	2.86e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	2.82e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	2.82e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.42e-06	2.77e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	2.7e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	2.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.36e-06	2.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.31e-06	2.65e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.27e-06	2.59e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.26e-06	2.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.2e-06	2.52e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.17e-06	2.48e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	2.47e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-06	2.38e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.04e-06	2.34e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.98e-06	2.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-06	2.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.94e-06	2.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-06	2.19e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	1.93e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.66e-06	1.9e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	1.74e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.42e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.24e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.68e-07	7.65e-06	CbGpPWpGaD
